BERGER DISEASE
Clinical trials for BERGER DISEASE explained in plain language.
Never miss a new study
Get alerted when new BERGER DISEASE trials appear
Sign up with your email to follow new studies for BERGER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New monthly shot aims to control kidney disease
Disease control OngoingThis study tests a drug called atacicept given once a month to adults with IgA nephropathy, a kidney disease. The goal is to see if it lowers certain proteins linked to the disease and is safe. About 90 people will take part in this Phase 2 trial.
Matched conditions: BERGER DISEASE
Phase: PHASE2 • Sponsor: Vera Therapeutics, Inc. • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
New hope for kidney disease: drug aims to slow damage in IgA nephropathy
Disease control OngoingThis phase 3 study tests the drug atacicept in 376 adults with IgA nephropathy, a kidney disease that can lead to kidney failure. The goal is to see if atacicept can reduce protein in the urine and slow the decline in kidney function compared to a placebo. Participants must have …
Matched conditions: BERGER DISEASE
Phase: PHASE3 • Sponsor: Vera Therapeutics, Inc. • Aim: Disease control
Last updated Jun 08, 2026 13:09 UTC